Key result
Sequential therapy involving fibrinolytic agents, anticoagulation, and decompressive surgery resulted in sustained venous patency without the need for chronic anticoagulation in effort thrombosis.
Why the study?
What is the optimal treatment strategy for primary effort thrombosis to achieve sustained venous patency?
Case Report (n=4)
What is the optimal treatment strategy for primary effort thrombosis to achieve sustained venous patency?
Sequential therapy involving fibrinolytic agents, anticoagulation, and first rib resection may be the treatment of choice for effort thrombosis to eliminate the need for long-term anticoagulation.
Answers are grounded in this paper and cite their sources.
Case success with sequential therapy suggests potential to avoid chronic anticoagulation; leaves open optimal strategy for effort thrombosis.
Primary axillary-subclavian vein thrombosis (effort thrombosis) is a unique variant of thoracic outlet syndrome that effects young, active adults. The majority of cases have been demonstrated to be secondary to contriction of the axillary- subclavian vein junction between the interval of the clavicle and the first thoracic rib. Owing to the limited clinical experience with this disorder, prevention of long-term disability has resulted in several proposed surgical procedures that have not always decreased late morbidity. Recently the availability of fibrinolytic agents has improved therapeutic results in primary thrombotic syndromes. The authors report 4 cases involving both acute and chronic effort thrombosis treated either by (1) sequential therapy involving fibrinolytic agents, anticoagulation, then decompressive surgery (first rib resection), (2) anticoagulation and first rib resection or (3) fibrinolytic agents and long term anticoagulation without surgery. Their experience with both acute and chronic effort thrombosis has resulted in sustained venous patency without the need for chronic anticoagulation in those patients who ultimately underwent rib resection as part of their treatment. The authors believe that this sequential therapy is the treatment of choice in the management of both phases of this syndrome and will eliminate the need for long-term anticoagulation and drastically reduce long-term disability.
No takes yet. Share an insight, caveat, or question.
Adams et al. (1991) conducted a case report in Primary axillary-subclavian vein thrombosis (effort thrombosis) (n=4). Sequential therapy involving fibrinolytic agents, anticoagulation, and decompressive surgery (first rib resection) was evaluated on Sustained venous patency without the need for chronic anticoagulation. Sequential therapy involving fibrinolytic agents, anticoagulation, and decompressive surgery resulted in sustained venous patency without the need for chronic anticoagulation in effort thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: